Advertisement
Organisation › Details
ImmunoPrecise (Group)
ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. ImmunoPrecise operates from state-of-the-art laboratory facilities located in Victoria, British Columbia, in collaboration with its wholly-owned subsidiary operations at ImmunoPrecise Antibodies Europe (formerly ModiQuest Research), in Oss, and U-Protein Express, in Utrecht, both in the Netherlands. The Company operates globally to offer a continuum of superior antibody services, from target analysis to pre-clinical studies. *
Start | 2019-07-05 existent | |
Industry | antibody | |
Industry 2 | BIOTECH | |
Street | 4464 Markham Street Vancouver Island Technology Park, Unit 3204 | |
City | V8Z 7X8 Victoria, BC | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: ImmunoPrecise Antibodies Ltd.. (6/26/19). "Press Release: ImmunoPrecise Guarantees Success for Customers of Their Well-established B Cell Select Antibody Discovery Platform". Victoria, BC. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for ImmunoPrecise (Group)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top